Innovative Therapeutics Lykos Therapeutics is actively developing investigational psychedelics aimed at addressing unmet mental health needs, particularly PTSD, positioning it as a forward-thinking biotech company focused on cutting-edge mental health solutions.

Regulatory Challenges Recent regulatory setbacks and major staff reductions suggest potential for strategic partnerships or consulting solutions to navigate compliance and regulatory hurdles in the psychedelic and mental health space.

Leadership Transitions The recent departure of key leadership, including the CEO and founder, indicates opportunities to offer leadership advisory, executive recruitment, or organizational development services tailored to high-growth biotech firms.

Funding & Growth With revenue estimated between $10M and $25M and ongoing clinical development efforts, Lykos presents opportunities for financial services, investment, or partnership solutions to support their scaling and research activities.

Tech Stack & Innovation Utilizing advanced technology platforms like AWS and data analytics tools, Lykos is likely open to innovative solutions in data management, cloud security, and analytics to optimize their research and regulatory processes.